share_log

HC Wainwright & Co. Maintains Buy on Rockwell Medical, Raises Price Target to $11

HC Wainwright & Co. Maintains Buy on Rockwell Medical, Raises Price Target to $11

HC Wainwright & Co.維持對Rockwell Medical的買入,將目標股價提高至11美元
Benzinga ·  2023/07/17 09:51

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and raises the price target from $9 to $11.

HC Wainwright & Co. 分析師Raghuram Selvaraju維持羅克韋爾醫療(納斯達克股票代碼:RMTI)的買入,並將目標股價從9美元上調至11美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論